Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Annals of Surgical Oncology
|
March 6, 2025
Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept
Martin B Niederle, Teresa Binter, Philipp Riss, et al.
Cancers
|
October 16, 2024
The Value of Pretherapeutic Basal Calcitonin Cut-Offs for the Therapeutic Strategy and Prediction of Long-Term Outcome of Patients with Medullary Thyroid Cancer-A 30-Year Single-Center Experience
Martin B Niederle, Teresa Binter, Philipp Riss, et al.
Frontiers in Endocrinology
|
August 6, 2024
Is intraoperative parathyroid monitoring during minimally invasive parathyroidectomy still justified?
Lindsay Hargitai, Daniela Boryshchuk, Melisa Arikan, et al.
Gland Surgery
|
December 16, 2024
Benefits of transitioning from transperitoneal laparoscopic to retroperitoneoscopic adrenalectomy-a single center experience
Joy Feka, Barbara Soliman, Melisa Arikan, et al.
Annals of Surgical Oncology
|
November 13, 2023
Feasibility of Autofluorescence Using Overlay Imaging for the Detection of Parathyroid Glands: Defining Standards
Melisa Arikan, Josef Hegazy, Sophie Mertlitsch, et al.
Langenbeck'S Archives of Surgery
|
June 13, 2025
Does size still matter? - Feasibility of posterior retroperitoneoscopic adrenalectomy for tumors >6cm
Joy Feka, Barbara Soliman, Melisa Arikan, et al.
Endocrine-Related Cancer
|
June 2, 2026
B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer
Teresa Binter, Erwin Tomasich, Philipp Melhorn, et al.
Gland Surgery
|
July 17, 2025
<i>RET</i> Y791F in MEN2: a variant presumed non-pathogenic, yet lacking conclusive evidence of insignificance
Teresa Binter, Martin Bruno Niederle, Melisa Arikan, et al.
Cancers
|
February 10, 2024
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?
Teresa Binter, Sabina Baumgartner-Parzer, Marie Helene Schernthaner-Reiter, et al.
Wiener Klinische Wochenschrift
|
December 22, 2020
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence
Lisa Steininger, David Chromy, David Bauer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Annals of Surgical Oncology
|
March 6, 2025
Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept
Martin B Niederle, Teresa Binter, Philipp Riss, et al.
Cancers
|
October 16, 2024
The Value of Pretherapeutic Basal Calcitonin Cut-Offs for the Therapeutic Strategy and Prediction of Long-Term Outcome of Patients with Medullary Thyroid Cancer-A 30-Year Single-Center Experience
Martin B Niederle, Teresa Binter, Philipp Riss, et al.
Frontiers in Endocrinology
|
August 6, 2024
Is intraoperative parathyroid monitoring during minimally invasive parathyroidectomy still justified?
Lindsay Hargitai, Daniela Boryshchuk, Melisa Arikan, et al.
Gland Surgery
|
December 16, 2024
Benefits of transitioning from transperitoneal laparoscopic to retroperitoneoscopic adrenalectomy-a single center experience
Joy Feka, Barbara Soliman, Melisa Arikan, et al.
Annals of Surgical Oncology
|
November 13, 2023
Feasibility of Autofluorescence Using Overlay Imaging for the Detection of Parathyroid Glands: Defining Standards
Melisa Arikan, Josef Hegazy, Sophie Mertlitsch, et al.
Langenbeck'S Archives of Surgery
|
June 13, 2025
Does size still matter? - Feasibility of posterior retroperitoneoscopic adrenalectomy for tumors >6cm
Joy Feka, Barbara Soliman, Melisa Arikan, et al.
Endocrine-Related Cancer
|
June 2, 2026
B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer
Teresa Binter, Erwin Tomasich, Philipp Melhorn, et al.
Gland Surgery
|
July 17, 2025
<i>RET</i> Y791F in MEN2: a variant presumed non-pathogenic, yet lacking conclusive evidence of insignificance
Teresa Binter, Martin Bruno Niederle, Melisa Arikan, et al.
Cancers
|
February 10, 2024
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?
Teresa Binter, Sabina Baumgartner-Parzer, Marie Helene Schernthaner-Reiter, et al.
Wiener Klinische Wochenschrift
|
December 22, 2020
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence
Lisa Steininger, David Chromy, David Bauer, et al.
Page
of 3